Impact of a clinical pharmacist-led, artificial intelligence-supported medication adherence program on medication adherence performance, chronic disease control measures, and cost savings.
Journal:
Journal of the American Pharmacists Association : JAPhA
PMID:
39426621
Abstract
BACKGROUND: Chronic diseases are the leading cause of disability and death in the United States. Clinical pharmacists have been shown to optimize health outcomes and reduce health care expenditures in patients with chronic diseases through improving medication adherence.